Navigation Links
CareFusion Provides Update On Form 10-K Filing
Date:9/14/2012

SAN DIEGO, Sept. 14, 2012 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN) today announced it has delayed filing its Annual Report on Form 10-K for the fiscal year ended June 30 beyond the Sept. 13 extended filing due date. As CareFusion indicated on Aug. 29, the company is consulting with the Securities and Exchange Commission (SEC) about its accounting policy for sales-type leases in its Pyxis® medication and supply dispensing product lines.

As a result of the filing delay, the company received a notice from the New York Stock Exchange (NYSE) indicating CareFusion is not currently in compliance with continued listing requirements under the timely filing criteria outlined in Section 802.01E of the NYSE-Listed Company Manual. The issuing of such notices is considered routine practice in situations when there are late filings with the SEC.

Under NYSE rules, CareFusion has six months from Sept. 13 to file its Form 10-K. Until CareFusion files its Form 10-K, CareFusion's common stock will remain listed on the NYSE under the symbol "CFN," but will be assigned a "LF" indicator to signify late filing status. The company can regain compliance with the NYSE listing standards at any time during this six-month period once it files its Form 10-K with the SEC.

CareFusion previously disclosed that it was consulting with the SEC about the company's accounting policy for its Pyxis sales-type leases. The consultation process with the SEC is ongoing. Once this process is complete, the company will assess any impact on its financial statements and file its Form 10-K as soon as practicable.

The matter does not affect CareFusion customers or the underlying fundamentals and cash flows of the company or its Pyxis business.

About CareFusion Corporation

CareFusion (NY
'/>"/>

SOURCE CareFusion Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
2. CareFusion Strengthens U.K. Presence With Acquisition of Medical Products Distributor
3. CareFusion Expands Infusion Pump Interoperability
4. CareFusion To Report Fourth Quarter And Fiscal 2012 Results On Aug. 9
5. CareFusion Reports Fourth Quarter and Fiscal 2012 Results
6. CareFusion Recognizes Best Of The Best U.S. Hospitals
7. MediPendant™ to Return to Television on May 20th New Television Campaign - Company Provides MediPendant™ Update
8. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
9. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
10. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
11. Elevate Provides Remote Access to Personal Health Records Using MyMedicalRecords.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 ... EPI) and Bloom Burton & Co. Ltd. ("Bloom Burton") ... lock-up (the "Lock-Up") 2,353,130 common shares of the Company ... subject to the Lock-Up. Of the Common Shares released ... immediately upon release from the Lock-Up while the remainder ...
(Date:2/27/2015)... , Feb. 27, 2015   Synageva BioPharma ... a biopharmaceutical company developing therapeutic products for rare ... (NORD™), the European Organisation for Rare Diseases™ (EURORDIS™), ... world in observing Rare Disease Day. ... patient organizations, industry, and other participants conduct special ...
(Date:2/27/2015)...  Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), ... 3D bioprinting technology, announced today that Keith ... present live at VirtualInvestorConferences.com on March 5th. ... for this Company update," said Mr. Murphy. "We ... of the exVive3D Liver, Bioprinted Human Tissue, commercialization ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4
... N.Y., Oct. 25, 2011 Misonix, Inc. (NASDAQ: ... that designs, manufactures and markets innovative therapeutic ultrasonic ... surgery, neurosurgery, laparoscopic surgery, and other surgical and ... the BoneScalpel™ Ultrasonic Bone Cutting System at the ...
... HIGHLIGHTS:2011 Results (all percentages are to comparable periods in 2010) ... to $626 million. Q3 sales grew organically by 4% with ... 4% and 2%, respectively.  Recently completed acquisitions contributed an additional ... additional 5% to reported sales growth in Q3. ...
Cached Medicine Technology:Misonix Exhibits BoneScalpel™ at the International Meeting on Advanced Spine Techniques 2Misonix Exhibits BoneScalpel™ at the International Meeting on Advanced Spine Techniques 3Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 2Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 3Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 4Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 5Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 6Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 7Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 8Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 9Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 10Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 11Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 12Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 13
(Date:2/27/2015)... According to court documents, Donna Pirolli was a ... and underwent a procedure during which a duodenoscope was ... the duodenoscope allegedly had not been properly cleaned, Donna ... (CRE). , A lawsuit has been proceeding ... of Ms. Pirolli alleging that Lutheran General Hospital was ...
(Date:2/27/2015)... 27, 2015 The winter season is here, ... expansion. When mold grows, it can be harmful to the ... avoid the consequences of mold growth with the help of ... offering tips on the best ways to prevent mold during ... makes perfect conditions for mold to thrive. Mold must be ...
(Date:2/27/2015)... Mediaplanet today announces the launch of ... that aims to bring blood health and cancer awareness ... stories in this edition go beyond the concept of ... hard-hitting advocacy, research and technological strides needed to develop ... Cancer Society, approximately every 3 minutes one person ...
(Date:2/27/2015)... “ Logical Operations ” was featured on NewsWatch as ... look at the latest and coolest technology products and ... for NewsWatch and a technology expert, conducted the review ... avoid cyber security threats. , If a person looks ... somewhere in the headlines. Well, cyber security is a ...
(Date:2/27/2015)... Miami Beach, Florida (PRWEB) February 27, 2015 ... largest non-profit organization devoted exclusively to funding innovative lymphoma ... series of education programs, outreach initiatives and patient services ... the South Florida community, returning to the greater Miami ... the La Gorce Country Club in Miami Beach on ...
Breaking Medicine News(10 mins):Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2Health News:A Way for Companies to Avoid Cyber Security Threats was Featured on NewsWatch Television on January 30, 2015 2Health News:Lymphoma Research Foundation Returns to Miami Beach For Exclusive Swirl Wine Tasting Event 2
... MSC Care Management, the industry,s leading provider of ... workers, compensation claimants nationwide, announced today that it ... company also focused on the workers, compensation industry. ... market, providing specialized workers, compensation services in four ...
... Calif. producer says they may have been mixed in ... -- The salmonella contamination behind the recall of 1 ... raw nuts involved in processing at a California plant, ... Lee Cohen, production manager for Setton International Foods Inc. ...
... information regarding organic production practices may not be explicitly ... March 31 Consumers in Ohio and elsewhere who ... produced with synthetic growth hormones will only be able ... for the organic label, according to the Organic Trade ...
... University of Delaware Study Demonstrates Economic ... WILMINGTON, Del., March 31 Members of Delaware,s business, ... for Health" (WWFH) of Delaware, a unique network of partners ... Delaware - and throughout America - at launches held at ...
... March 31 Biopure Corporation (Nasdaq: BPUR ) ... Nasdaq Stock Market. By letter dated March 24, 2009, ... its Form 10-Q for the fiscal quarter ended January 31, ... Rules. The company filed the report and received a ...
... MILLION MARK IN DONATED CAREMINNEAPOLIS, March 31 The ... 2,500 volunteer dental professionals throughout Minnesota provided their services ... afford the care. The annual Give Kids a ... dental care."It was wonderful to see a record number ...
Cached Medicine News:Health News:MSC Acquires Optimal Translation & Transportation 2Health News:Raw Nuts Could Be Salmonella Source in Pistachios: Report 2Health News:Raw Nuts Could Be Salmonella Source in Pistachios: Report 3Health News:Organic Left Standing as the Gold Standard for Consumers Looking to Avoid Food Produced With Synthetic Growth Hormones 2Health News:Organic Left Standing as the Gold Standard for Consumers Looking to Avoid Food Produced With Synthetic Growth Hormones 3Health News:Coalition of Business, Labor, Academia and Bioscience Groups to Promote Medical Innovation, Spark Economic Growth 2Health News:Coalition of Business, Labor, Academia and Bioscience Groups to Promote Medical Innovation, Spark Economic Growth 3Health News:Coalition of Business, Labor, Academia and Bioscience Groups to Promote Medical Innovation, Spark Economic Growth 4Health News:Biopure Receives Notices About Nasdaq Listing Compliance 2Health News:Biopure Receives Notices About Nasdaq Listing Compliance 3
... 1 Gentamicin Bone Cement, a high viscosity ... international market for over a decade, eliminates ... cement. The premixed powder helps to prevent ... Bone Cement provides the same proven characteristics ...
... for ocular precision tonometry. ,The PASCAL Dynamic ... contact tonometer for ophthalmological applications. The slitlamp-mounted ... pressure (IOP) and of ocular pulse amplitude ... few seconds. It measures pulsatile IOP directly ...
... Inserted into the punctal opening to block ... provide extended temporary relief of dry eye symptoms:, ... Dry Eye Syndrome and the dry eye components ... after ocular surgery to prevent dry eye related ...
The original tapered shaft punctum plug. Easy to insert and remove, the EaglePlug is the economical dry eye solution with a proven record of success. Designed For:, Maximal retention, Easy insertion,...
Medicine Products: